Table 2

Demographic and clinicopathological features of LS and sporadic CRCs

ParametersTotal, n (%) n = 628LS, n (%) n = 88Sporadic, n (%) n = 540P value
Gender0.48
 Male362 (57.9%)54 (61.4%)308 (57.4%)
 Female263 (42.1%)34 (38.6%)229 (42.6%)
Age (years)<0.001
 Median (range)59 (22–86)53 (22–71)60 (23–86)
 <55250 (39.8%)53 (60.2%)197 (36.5%)
 ≥55378 (60.2%)35 (39.8%)343 (63.5%)
Clinical stage0.001
 I55 (9.6%)11 (13.6%)44 (8.9%)
 II282 (49.2%)53 (65.4%)229 (46.5%)
 III203 (35.4%)15 (18.5%)188 (38.2%)
 IV33 (5.8%)2 (2.5%)31 (6.3%)
Location<0.001
 Left321 (56.6%)26 (32.5%)295 (60.6%)
 Right246 (43.4%)54 (67.5%)192 (39.4%)
Differentiation0.051
 Low114 (22.6%)21 (33.3%)93 (21.0%)
 Medium369 (73.1%)38 (60.3%)331 (74.9%)
 High22 (4.4%)4 (6.3%)18 (4.1%)
Mucinous<0.001
 No292 (68.1%)10 (33.3%)282 (70.7%)
 Yes137 (31.9%)20 (66.7%)117 (29.3%)
MSI<0.001
 MSI-H301 (47.9%)80 (90.9%)221 (40.9%)
 MSI-L12 (1.9%)1 (1.1%)11 (2.0%)
 MSS315 (50.2%)7 (8.0%)308 (57.0%)
MMR-IHC<0.001
 dMMR378 (60.2%)87 (98.9%)291 (53.9%)
 pMMR250 (39.8%)1 (1.1%)249 (46.1%)

MMR, mismatch repair; dMMR, deficient MMR; pMMR, proficient MMR; MSI, microsatellite instability; MSI-H, MSI-high; MSI-L, MSI-low; MSS, microsatellite stability.